Delhi High Court Rules In Favour Of Medanta, Decrees Trademark Suit Against Seller Of 'Medanta Capsule'

The Delhi High Court on 24 September ruled in favour of Global Health Limited, which runs Medanta hospitals, in its trademark infringement suit against a seller marketing an ayurvedic weight management medicine as “Medanta Capsule”.

Justice Purushaindra Kumar Kaurav allowed the hospital operator's application under Order VIII Rule 10 of the CPC after the sole contesting defendant neither filed a written statement nor opposed the relief sought.

The Bench had restrained the seller in November 2024 from manufacturing or selling any goods under the “MEDANTA” mark, finding a prima facie case that such use was likely to confuse the public into associating the products with the hospital. It also noted that medicinal products require a higher degree of scrutiny because of the public interest involved.

Two listing platforms, Infocom Network and IndiaMart, were later dropped from the suit after complying with the injunction.

The hospital subsequently informed the Court that a reference to “Vedanta Capsule” remained on the seller's website despite the injunction. The Bench directed the seller to correct the website and file a compliance affidavit, which was subsequently complied with.

As the interim relief had been fully availed and no continuing infringement remained, the High Court decreed the suit in terms of the hospital's prayers and directed that a decree sheet be drawn.